Access cutting-edge large b-cell lymphoma treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access large b-cell lymphoma specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related large b-cell lymphoma treatment provided free
The purpose of this study is to compare the effectiveness and safety of golcadomide in combination with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy vs placebo in combination with R-CHOP chemotherapy in participants with previously untreated high-risk large B-cell lymphoma (LBCL).
Sponsor: Celgene
Check if you qualify for this large b-cell lymphoma clinical trial in San Francisco, CA
If you're searching for large b-cell lymphoma treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.